BioSim™ Ramucirumab (Human) ELISA Kit

BioSim™ Ramucirumab (Human) ELISA Kitis available at Gentaur for Next week Delivery.

This ELISA kit is used for in vitro quantitative determination of Ramucirumab.

Description:

Ramucirumab is a human monoclonal antibody (IgG1) against vascular endothelial growth factor receptor 2 (VEGFR2), a type II trans-membrane tyrosine kinase receptor expressed on endothelial cells. By binding to VEGFR2, Ramucirumab prevents binding of its ligands (VEGF-A, VEGF-C, and VEGF-D), thereby preventing VEGF-stimulated receptor phosphorylation and downstream ligand-induced proliferation, permeability, and migration of human endothelial cells. BioSim™ Ramucirumab ELISA kit is a solid phase enzyme-linked immunosorbent assay (ELISA) based on the sandwich principle. Standards and samples (serum or plasma) are incubated in the microtitre plate coated with the reactant for Ramucirumab. After incubation, the wells are washed. A horse radish peroxidase (HRP) conjugated probe is added and binds to Ramucirumab captured by the reactant on the surface of the wells. Following incubation, wells are washed and the bound enzymatic activity is detected by addition of chromogen-substrate. The color developed is proportional to the amount of Ramucirumab in the sample or standard.

Applications: Cross Reactivity: Except for Ramucirumab, there is no cross reaction with other therapeutic antibodies and native serum immunoglobins. Sensitivity: 20 ng/ml Detection Range: 20 - 600 ng/ml Recovery rate: ˂100 ± 30% with normal human serum samples with known concentrations This ELISA kit is used for in vitro quantitative determination of Ramucirumab Assay Precision: Intra-Assay: CV < 30%; Inter-Assay: CV < 30% (CV (%) = SD/mean X 100)

Sample Typ:e Plasma,Serum

Alternate Name: Ramucirumab elisa kit

Features and Benefits:

Detection Range: 20 - 600 ng/ml Sensitivity: 20 ng/ml Assay Precision: Intra-Assay: CV < 30%; Inter-Assay: CV < 30% (CV (%) = SD/mean X 100) This ELISA kit is used for in vitro quantitative determination of Ramucirumab Cross Reactivity: Except for Ramucirumab, there is no cross reaction with other therapeutic antibodies and native serum immunoglobins. Recovery rate: ˂100 ± 30% with normal human serum samples with known concentrations